ACTION AND MECHANISM

- Eye lubricant. A combination of two substances that moisturize the ocular mucosa.

* Hypromellose: increases tear viscosity and contact time with the ocular mucosa.

* Sodium chloride: moistens the corneal mucosa.

SENIORS

No specific problems have been described in the elderly that require dosage adjustment.

PATIENT ADVICE

- Consult your doctor and/or pharmacist if symptoms worsen or do not improve within the next 72 hours, or if you experience pain, eye irritation, or visual disturbances.

CONTRAINDICATIONS

- Hypersensitivity to any component of the medication.

EFFECTS ON DRIVING

It does not appear to significantly affect driving ability. However, as with any other ophthalmic medication, blurred vision may occur immediately after use. It is recommended to avoid driving until vision is normal.

PREGNANCY

Animal safety : no data available.

Safety in humans : accepted use, due to the lack of significant absorption.

Effects on fertility : No specific studies have been conducted in humans.

PHARMACOKINETICS

Ophthalmic route:

- Absorption: Significant absorption through the cornea is not expected.

INDICATIONS

- Relief from [DRY EYE] when the eye is subjected to irritating agents that cause dry eye and discomfort.

FUNDED INDICATIONS

- Relief of dry eye in patients with [SJOGREN'S SYNDROME].

INTERACTIONS

No interaction studies have been performed.

LACTATION

Animal safety : no data available.

Safety in humans : accepted use, due to the lack of significant absorption.

CHILDREN

Safety and efficacy in children and adolescents under 18 years of age have not been evaluated, so dosage recommendations cannot be made.

RULES FOR CORRECT ADMINISTRATION

Extreme precautions should be taken to avoid contaminating the eye drops throughout the entire administration process. To do this, wash your hands before administering the medication and avoid contact of the dropper with any body surface, including the eyelids and surrounding areas.

"Rules for administering eye drops"

1. Tilt your head back.

2. Pull down your lower eyelid with an index finger and look up.

3. Instill one drop into the conjunctival sac, holding the bottle vertically with the dropper pointing downwards.

4. After applying the drop, blink repeatedly to distribute the drop. To reduce possible systemic absorption, it is recommended to press the tear sac for one minute or close the eyelids tightly for 2-3 minutes immediately after administering the drop.

If other ophthalmic medications are being used, it is recommended to space administrations at least 5 minutes apart. More viscous formulations, such as ophthalmic ointments, are recommended to be administered last.

POSOLOGY

- Adults: 1-2 drops in each affected eye. May be repeated at the discretion of a doctor.

- Children and adolescents < 18 years: safety and efficacy have not been evaluated.

- Elderly: no dosage adjustment required.

Missed dose : Administer the missed dose as soon as possible, unless it is almost time for the next dose. Administer the next dose at the regular time. Do not double the next dose.

DOSAGE IN LIVER FAILURE

No specific dosage recommendations have been made.

DOSAGE IN RENAL FAILURE

No specific dosage recommendations have been made.

ADVERSE REACTIONS

Adverse reactions are described according to each frequency interval, considering very frequent (>10%), frequent (1-10%), unfrequent (0.1-1%), rare (0.01-0.1%), very rare (<0.01%) or of unknown frequency (cannot be estimated from the available data).

- Allergic: frequency unknown [HYPERSENSITIVITY REACTIONS].

- Ophthalmological: uncommon [BLURRED VISION], [EYE ITCHING], [EYE PAIN], [EYE IRRITATION].

OVERDOSE

Symptoms : There is no clinical experience. The risk of overdose does not appear significant due to the route of administration and low absorption.

Treatment : not required.